Sign Up

About ARALAST NP Therapy

ARALAST NP ARALAST NP

Events

Event Location Date
Alpha-1 Education Day Des Moines, IA

August 28, 2010

Alpha-1 Education Day Las Vegas, NV

September 25, 2010

Alpha-1 Education Day Seattle, WA

October 23, 2010

Alpha-1 Education Day Temple, TX

November 6, 2010

To learn about events of interest to healthcare professionals, visit Conferences.

ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]

ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.

Please review the Important Risk Information and the Full Prescribing Information

Please review the Important Risk Information and the Full Prescribing Information